Resolution of the Board of Directors on the Approval of the List of Candidates for the Board of Directors for the 2024–2029 Term
Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements Compared to the Same Period in 2022
Appellate Judgment of the Ho Chi Minh City People’s Court regarding the dispute over a goods sale and purchase contract between DBD and Dong Nam
Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements Compared to the Same Period in 2022
Report on Change in Ownership of Major Shareholders and Investors Holding 5% or More of Closed-End Fund Certificates
List of Related Persons of the Company in the Semi-Annual Corporate Governance Report 2023, No. 858/BC-DBD dated July 29, 2023
Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements for the Second Quarter of 2023 Compared to the Same Period in 2022
Resolution of the Board of Directors No. 814/NQ-HĐQT dated July 17, 2023 on the Selection of the Auditing Firm for 2023
Resolution of the Board of Directors No. 736/NQ-DBD-HĐQT dated June 30, 2023 on the Implementation of the Investment in a Small-Volume Parenteral Drug Manufacturing Plant
Corporate Governance Regulations of Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) – 2023
Explanation of the difference of 10% or more in NPAT of the 3rd quarter consolidated financial statements of the third quarter of 2022 compared to the same period last year
Decision of the Board of Directors: Retiring from holding the position of Auditor for Ms. Nguyen Thi Mai Hoa, Appointing KTT for Mr. Do Huy Phuong from September 1, 2022
Explanation of the difference of 10% or more in NPAT of the semi-annual financial statements of 2022 compared to the same period last year
